Help us transform the next generation of drug discovery
As a company, ZYMEDI has the ability and flexibility to partner on a variety of different levels, including R&D joint ventures, strategic investments, and in-licensing. Our purpose to transform drug discovery gives us the scope to engage with partners on many levels.
If you’d like to collaborate with a truly novel, innovative group, contact us today.
ZYMEDI wins top prize in the oncology disease space
To help foster healthcare startups, BMS Korea sponsors the “Seoul BMS Innovation Square Challenge” award with the Seoul Municipal Government and the Korea Health Industry Development Institute (KHIDI).
The challenge is an open innovation partnering program jointly sponsored by BMS Korea and KHIDI to discover and develop innovative technologies that can change the lives of patients with severe diseases.
ZYMEDI was awarded the top prize in the oncology disease area.
